Key facts
- This page summarizes Robert Paul's Form 4 filing for Alector, Inc. (ALEC).
- 8 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 11 Aug 2021, 18:23.
Robert Paul - 09 Aug 2021 Form 4 Insider Report for Alector, Inc. (ALEC)
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- ALEC
- Reported as of
- 09 Aug 2021
- Net transaction value
- -$378,522
- SEC form
- 4
- Accepted by SEC
- 11 Aug 2021, 18:23:30 UTC
- Prior SEC filing
- 08 Jul 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ David Oh, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Robert Paul filed Form 4 for Alector, Inc. (ALEC) on 11 Aug 2021.
Change
- Previous filing in this sequence was filed on 08 Jul 2021.
- Current net transaction value: -$378,522.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALEC
transaction
Common Stock
Options Exercise
- Transaction value
- $79,079
- Shares
- +9,691
- Change %
- +4.1%
- Price
- $8.16
- Shares after
- 244,010
- Date
- 09 Aug 2021
- Ownership
- Direct
ALEC
transaction
Common Stock
Options Exercise
- Transaction value
- $88,563
- Shares
- +8,734
- Change %
- +3.6%
- Price
- $10.14
- Shares after
- 252,744
- Date
- 09 Aug 2021
- Ownership
- Direct
ALEC
transaction
Common Stock
Options Exercise
- Transaction value
- $77,604
- Shares
- +4,525
- Change %
- +1.8%
- Price
- $17.15
- Shares after
- 257,269
- Date
- 09 Aug 2021
- Ownership
- Direct
ALEC
transaction
Common Stock
Sale
- Transaction value
- $615,430
- Shares
- -22,650
- Change %
- -8.8%
- Price
- $27.17
- Shares after
- 234,619
- Date
- 09 Aug 2021
- Ownership
- Direct
- Footnotes
- F1, F2
ALEC
transaction
Common Stock
Sale
- Transaction value
- $8,337
- Shares
- -300
- Change %
- -0.13%
- Price
- $27.79
- Shares after
- 234,319
- Date
- 09 Aug 2021
- Ownership
- Direct
- Footnotes
- F1, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ALEC
transaction
Derivative
Employee Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -9,691
- Change %
- -11%
- Price
- $0.000000
- Shares after
- 81,000
- Date
- 09 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 9,691
- Exercise price
- $8.16
- Footnotes
- F4
ALEC
transaction
Derivative
Employee Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -8,734
- Change %
- -22%
- Price
- $0.000000
- Shares after
- 31,250
- Date
- 09 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,734
- Exercise price
- $10.14
- Footnotes
- F5
ALEC
transaction
Derivative
Employee Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -4,525
- Change %
- -5.1%
- Price
- $0.000000
- Shares after
- 84,450
- Date
- 09 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,525
- Exercise price
- $17.15
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.71 to $27.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
Footnote F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.71 to $27.83, inclusive.
Footnote F4
Shares subject to the option vest in 48 equal monthly installments beginning on August 2, 2018.
Footnote F5
One-fourth of the total number of shares subject to the option grant vested on November 1, 2019, and an additional 1/48th of the shares subject vest monthly thereafter.
Footnote F6
Shares subject to the option vest in 48 equal monthly installments beginning on December 6, 2019.